Hold Big Pharma Accountable for their Vaccines! End Legal Indemnity for Vaccine Manufacturers
Big Pharma has been protected by the Federal Government for far too long.
Many Australian families have reported incidents of serious ‘vacccine’ injury as a result of the experimental COVID-19 shots. And yet, because of a sweetheart deal with the Federal Government, vaccine manufacturers are untouchable.
Well, they have legal indemnity, which means that Big Pharma companies, who have made a fortune off the experimental COVID-19 vaccines, can't be taken to court, even when Australians suffer severe adverse effects. If you or a loved one has been harmed, you're out of luck, with no legal recourse.
But now, we have a window of opportunity to make things right.
A bill has been introduced into the Parliament by Senator Ralph Babet that will remove legal indemnity for vaccine manufacturers.
That bill – the Public Governance, Performance, and Accountability Amendment (Vaccine Indemnity) Bill 2023 – is currently subject to a Senate inquiry. Submissions to that inquiry are being taken by the Senate Standing Committees on Finance and Public Administration until 29 September 2023.
The arguments in favour of passing this bill are overwhelming.
It's about accountability and safety. Without having to worry about legal repercussions, vaccine manufacturers aren't incentivised to maintain the highest safety standards.
It's about trust and transparency. When people know that manufacturers can be held responsible, they can trust the product more.
It's also about consumer rights. Without indemnity protections, manufacturers will be less inclined to rush products to the market without thorough testing. This could lead to better market competition and higher safety profiles. Legal challenges can lead to a greater understanding of potential vaccine side effects.
Moreover, holding manufacturers financially responsible ensures that costs associated with potential side effects aren't borne solely by individuals or the public healthcare system.
Removing indemnity would align the vaccine industry with others, where product liability is a key component of doing business.
If enough members of the public inform the Senate Standing Committees on Finance and Public Administration inquiry that they wish for the Public Governance, Performance, and Accountability Amendment (Vaccine Indemnity) Bill 2023 to be passed, then the committee may recommend the Senate pass the bill.
We're at a crossroads. Without action, the Senate might reject the bill, leaving us where we started: powerless.
But with your help, we can win this fight.
The Senate could pass the bill, ending Big Pharma's legal protection, and paving the way for a safer and more accountable vaccine industry.
The clock is ticking. We need as many signatures as possible to make an impression.